Press Release: Medigene enters Cooperative Research and Development Agreement with the National Cancer Institute to evaluate the use of Medigene's proprietary T cell receptors in novel cell constructs
Press Release: Medigene enters Cooperative Research and Development Agreement with the National Cancer Institute to evaluate the use of Medigene's proprietary T cell receptors in novel cell constructs
Source: finanznachrichten.de